Brief: EBR Systems Responds To Media Speculation On Serious Patient Complications With Wise System
24/07/2026 07:31
BRIEF-EBR Systems Responds To Media Speculation On Serious Patient Complications With Wise System July 24 (Reuters) - EBR Systems Inc EBR.AX:
EBR RESPONDS TO SPECULATION
RESPONDS TO SPECULATION ON SERIOUS PATIENT COMPLICATIONS WITH WISE SYSTEM
TWO PATIENTS DEVELOP VENTRICULAR FIBRILLATION POST-IMPLANT; ONE PATIENT DIES DURING POST-IMPLANT ECHOCARDIOGRAMS
EVENTS ATTRIBUTED TO EXTERNAL ECHOCARDIOGRAPHY, NOT WISE SYSTEM FUNCTION
CO'S INTERNAL ASSESSMENT IS THAT THIS IS AN ISOLATED EVENT RELATED TO A DISCLOSED RISK
EVENT UNDER REVIEW BY U.S. FDA
REPORTS NO ONGOING CONCERN; OPERATIONS CONTINUE AS USUAL
Further company coverage: EBR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026